Related references
Note: Only part of the references are listed.Impairing temozolomide resistance driven by glioma stem-like cells with adjuvant immunotherapy targeting O-acetyl GD2 ganglioside
Julien Fleurence et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Profiling of O-acetylated Gangliosides Expressed in Neuroectoderm Derived Cells
Sumeyye Cavdarli et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
New era of research on cancer-associated glycosphingolipids
Koichi Furukawa et al.
CANCER SCIENCE (2019)
Approach for Profiling of Glycosphingolipid Glycosylation by Multiplexed Capillary Gel Electrophoresis Coupled to Laser-Induced Fluorescence Detection To Identify Cell-Surface Markers of Human Pluripotent Stem Cells and Derived Cardiomyocytes
Charlotte Rossdam et al.
ANALYTICAL CHEMISTRY (2019)
Gangliosides profiling in serum of breast cancer patient: GM3 as a potential diagnostic biomarker
Qinying Li et al.
GLYCOCONJUGATE JOURNAL (2019)
Gangliosides: The Double-Edge Sword of Neuro-Ectodermal Derived Tumors
Sumeyye Cavdarli et al.
BIOMOLECULES (2019)
Identification of 9-O-acetyl-N-acetylneuraminic acid (Neu5,9Ac2) as main O-acetylated sialic acid species of GD2 in breast cancer cells
Sumeyye Cavdarli et al.
GLYCOCONJUGATE JOURNAL (2019)
Antibodies to watch in 2019
Helene Kaplon et al.
MABS (2019)
Nanobody Engineering: Toward Next Generation Immunotherapies and Immunoimaging of Cancer
Timothee Chanier et al.
ANTIBODIES (2019)
Alterations in sialic-acid O-acetylation glycoforms during murine erythrocyte development
Vinay S. Mahajan et al.
GLYCOBIOLOGY (2019)
Neuroblastoma chemotherapy can be augmented by immunotargeting O-acetyl-GD2 tumor-associated ganglioside
S. Faraj et al.
ONCOIMMUNOLOGY (2018)
Isobaric Labeling of Intact Gangliosides toward Multiplexed LC-MS/MS-Based Quantitative Analysis
Rodell C. Barrientos et al.
ANALYTICAL CHEMISTRY (2018)
Enhancement of malignant properties of human glioma cells by ganglioside GD3/GD2
Taiji Iwasawa et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2018)
Differential roles of gangliosides in malignant properties of melanomas
Yuhsuke Ohmi et al.
PLOS ONE (2018)
Carbohydrate Targets for CAR T Cells in Solid Childhood Cancers
Claudia Rossig et al.
FRONTIERS IN ONCOLOGY (2018)
Safety and efficacy of the antiganglioside GD3 antibody ecromeximab (KW2871) combined with high-dose interferon-2b in patients with metastatic melanoma
Ahmad A. Tarhini et al.
MELANOMA RESEARCH (2017)
Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics
Peter Bannas et al.
FRONTIERS IN IMMUNOLOGY (2017)
Strategy for Comprehensive Profiling and Identification of Acidic Glycosphingolipids Using Ultra-High-Performance Liquid Chromatography Coupled with Quadrupole Time-of-Flight Mass Spectrometry
Ting Hu et al.
ANALYTICAL CHEMISTRY (2017)
Gangliosides: Structures, Biosynthesis, Analysis, and Roles in Cancer
Sophie Groux-Degroote et al.
CHEMBIOCHEM (2017)
Targeting and killing glioblastoma with monoclonal antibody to O-acetyl GD2 ganglioside
Julien Fleurence et al.
ONCOTARGET (2016)
9-O-Acetylation of sialic acids is catalysed by CASD1 via a covalent acetyl-enzyme intermediate
Anna-Maria T. Baumann et al.
NATURE COMMUNICATIONS (2015)
Epigenetic activation of mouse ganglioside synthase genes: implications for neurogenesis
Yi-Tzang Tsai et al.
JOURNAL OF NEUROCHEMISTRY (2014)
Chimeric Antibody c. 8B6 to O-Acetyl-GD2 Mediates the Same Efficient Anti-Neuroblastoma Effects as Therapeutic ch14.18 Antibody to GD2 without Antibody Induced Allodynia
Mickael Terme et al.
PLOS ONE (2014)
Cell cycle arrest and apoptosis induced by O-acetyl-GD2-specific monoclonal antibody 8B6 inhibits tumor growth in vitro and in vivo
Denis Cochonneau et al.
CANCER LETTERS (2013)
Estradiol Represses the GD3 Synthase Gene ST8SIA1 Expression in Human Breast Cancer Cells by Preventing NFκB Binding to ST8SIA1 Promoter
Marie Bobowski et al.
PLOS ONE (2013)
How Do Gangliosides Regulate RTKs Signaling?
Sylvain Julien et al.
Cells (2013)
Enhancement of malignant properties of human osteosarcoma cells with disialyl gangliosides GD2/GD3
Hidenobu Shibuya et al.
CANCER SCIENCE (2012)
Biosynthesis of the major brain gangliosides GD1a and GT1b
Elizabeth R. Sturgill et al.
GLYCOBIOLOGY (2012)
Disialyl gangliosides enhance tumor phenotypes with differential modalities
Koichi Furukawa et al.
GLYCOCONJUGATE JOURNAL (2012)
Ganglioside GD2 identifies breast cancer stem cells and promotes tumorigenesis
Venkata Lokesh Battula et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Anti-CD3 x anti-GD2 bispecific antibody redirects T-cell cytolytic activity to neuroblastoma targets
Maxim Yankelevich et al.
PEDIATRIC BLOOD & CANCER (2012)
Bispecific antibodies engage T cells for antitumor immunotherapy
Bryan D. Choi et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2011)
The human Cas1 protein: A sialic acid-specific O-acetyltransferase?
Sigrid Arming et al.
GLYCOBIOLOGY (2011)
Targeting the GD3 acetylation pathway selectively induces apoptosis in glioblastoma
Suzanne M. Birks et al.
NEURO-ONCOLOGY (2011)
A Monoclonal Antibody to O-Acetyl-GD2 Ganglioside and Not to GD2 Shows Potent Anti-Tumor Activity without Peripheral Nervous System Cross-Reactivity
Nidia Alvarez-Rueda et al.
PLOS ONE (2011)
Ganglioside GD3 Enhances Adhesion Signals and Augments Malignant Properties of Melanoma Cells by Recruiting Integrins to Glycolipid-enriched Microdomains
Yuki Ohkawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
New Antibody Conjugates in Cancer Therapy
Serengulam V. Govindan et al.
THESCIENTIFICWORLDJOURNAL (2010)
Current Constructs and Targets in Clinical Development for Antibody-Based Cancer Therapy
P. M. Deckert
CURRENT DRUG TARGETS (2009)
Cloning and transcriptional regulation of genes responsible for synthesis of Gangliosides
Guichao Zeng et al.
CURRENT DRUG TARGETS (2008)
Isolation and properties of two sialate-O-acetylesterases from horse liver with 4- and 9-O-acetyl specificities
Roland Schauer et al.
GLYCOCONJUGATE JOURNAL (2008)
O-Acetylation of GD3 Prevents its Apoptotic Effect and Promotes Survival of Lymphoblasts in Childhood Acute Lymphoblastic Leukaemia
Kankana Mukherjee et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Ganglioside 9-O-acetyl GD3 expression is upregulated in the regenerating peripheral nerve
V. T. Ribeiro-Resende et al.
NEUROSCIENCE (2007)
9-O-acetyl GD3 protects tumor cells from apoptosis
B Kniep et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Expression of gangliosides on glial and neuronal cells in normal and pathological adult human brain
S Marconi et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Ganglioside GD3 promotes cell growth and invasion through p130Cas and paxillin in malignant melanoma cells
K Hamamura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Acetylation suppresses the proapoptotic activity of GD3 ganglioside
F Malisan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Gangliosides with O-acetylated sialic acids in tumors of neuroectodermal origin
G Kohla et al.
NEUROCHEMICAL RESEARCH (2002)
Detection of sialic acids and gangliosides with special reference to 9-O-acetylated species in basaliomas and normal human skin
C Fahr et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2001)
Cell adhesion/recognition and signal transduction through glycosphingolipid microdomain
S Hakomori
GLYCOCONJUGATE JOURNAL (2000)
Share Paper
